DE69616515D1 - Benzothiazindioxide als endothelinantagonisten - Google Patents
Benzothiazindioxide als endothelinantagonistenInfo
- Publication number
- DE69616515D1 DE69616515D1 DE69616515T DE69616515T DE69616515D1 DE 69616515 D1 DE69616515 D1 DE 69616515D1 DE 69616515 T DE69616515 T DE 69616515T DE 69616515 T DE69616515 T DE 69616515T DE 69616515 D1 DE69616515 D1 DE 69616515D1
- Authority
- DE
- Germany
- Prior art keywords
- endothelin
- endothelinantagonists
- preparation
- benzothiazine dioxides
- dioxides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Dental Preparations (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/393,143 US5599811A (en) | 1995-02-21 | 1995-02-21 | Benzothiazine dioxides as endothelin antagonists |
| PCT/US1996/001093 WO1996026195A1 (en) | 1995-02-21 | 1996-01-26 | Benzothiazine dioxides as endothelin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69616515D1 true DE69616515D1 (de) | 2001-12-06 |
| DE69616515T2 DE69616515T2 (de) | 2002-05-16 |
Family
ID=23553452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69616515T Expired - Fee Related DE69616515T2 (de) | 1995-02-21 | 1996-01-26 | Benzothiazindioxide als endothelinantagonisten |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5599811A (de) |
| EP (1) | EP0811001B1 (de) |
| JP (1) | JPH11501013A (de) |
| KR (1) | KR19980702358A (de) |
| CN (1) | CN1071327C (de) |
| AT (1) | ATE207911T1 (de) |
| AU (1) | AU720036B2 (de) |
| BG (1) | BG62613B1 (de) |
| CA (1) | CA2211027A1 (de) |
| CZ (1) | CZ294412B6 (de) |
| DE (1) | DE69616515T2 (de) |
| DK (1) | DK0811001T3 (de) |
| EE (1) | EE03564B1 (de) |
| ES (1) | ES2167544T3 (de) |
| FI (1) | FI973380A (de) |
| GE (1) | GEP20001969B (de) |
| HU (1) | HUP9800273A3 (de) |
| NO (1) | NO308897B1 (de) |
| NZ (1) | NZ302116A (de) |
| PL (1) | PL321866A1 (de) |
| PT (1) | PT811001E (de) |
| RO (1) | RO116898B1 (de) |
| RU (1) | RU2164225C2 (de) |
| SK (1) | SK284275B6 (de) |
| UA (1) | UA47424C2 (de) |
| WO (1) | WO1996026195A1 (de) |
| ZA (1) | ZA961342B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962490A (en) * | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US6541498B2 (en) | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6030991A (en) * | 1993-05-20 | 2000-02-29 | Texas Biotechnology Corp. | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6376523B1 (en) | 1994-05-20 | 2002-04-23 | Texas Biotechnology Corporation | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| ATE245447T1 (de) * | 1995-06-02 | 2003-08-15 | Shionogi & Co | Inhibitor von gehirnödemen |
| US5804585A (en) * | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| US5783705A (en) * | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| CA2281090C (en) | 1997-04-28 | 2005-06-07 | Texas Biotechnology Corporation | Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| EP0995742A4 (de) | 1997-06-27 | 2004-08-25 | Fujisawa Pharmaceutical Co | Sulfonamidverbindungen und ihre medizinische verwendung |
| DE69824863T2 (de) | 1997-09-05 | 2005-06-30 | Warner-Lambert Co. Llc | Benzothiazindioxid-endothelin antagonisten und verfahren zu ihrer herstellung |
| GB2337048B (en) * | 1998-05-05 | 2000-06-28 | Warner Lambert Co | 2,1,3-Benzothiadiazole containing endothelin antagonists |
| JP2003535061A (ja) * | 2000-05-31 | 2003-11-25 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | エンドセリン受容体拮抗剤および疼痛軽減特性を有する抗癲癇化合物または鎮痛剤の複合物 |
| US20020115661A1 (en) * | 2000-12-07 | 2002-08-22 | Keller Laurence Harvey | Method for treating chronic obstructive pulmonary disease |
| CA2641952C (en) * | 2006-04-13 | 2011-02-01 | Actelion Pharmaceuticals Ltd | Treatment of early stage idiopathic pulmonary fibrosis |
| FR2942797B1 (fr) * | 2009-03-03 | 2011-04-29 | Pf Medicament | Derives de benzothiazines, leur preparation et leur application a titre de medicaments |
| CN110121343B (zh) | 2016-09-12 | 2023-11-03 | 整体健康 | 用作gpr120调节剂的双环化合物 |
| CN114671827A (zh) * | 2020-12-24 | 2022-06-28 | 杭州百新生物医药科技有限公司 | 邻苯甲酰磺酰亚胺类衍生物及其应用 |
| CN112521384B (zh) * | 2021-01-13 | 2021-11-02 | 湖北大学 | 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3237473A1 (de) * | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel |
| CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
| JPH0441483A (ja) * | 1990-06-07 | 1992-02-12 | Tanabe Seiyaku Co Ltd | ベンゾチアジン誘導体及びその製法 |
| RO117847B1 (ro) * | 1991-11-05 | 2002-08-30 | Smithkline Beecham Corp | Derivati de indan, procedeu de preparare, compozitie farmaceutica care ii contine si metoda de tratament |
| US5389620A (en) * | 1993-08-18 | 1995-02-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
-
1995
- 1995-02-21 US US08/393,143 patent/US5599811A/en not_active Expired - Fee Related
-
1996
- 1996-01-26 HU HU9800273A patent/HUP9800273A3/hu unknown
- 1996-01-26 CA CA002211027A patent/CA2211027A1/en not_active Abandoned
- 1996-01-26 ES ES96903708T patent/ES2167544T3/es not_active Expired - Lifetime
- 1996-01-26 AT AT96903708T patent/ATE207911T1/de not_active IP Right Cessation
- 1996-01-26 WO PCT/US1996/001093 patent/WO1996026195A1/en active IP Right Grant
- 1996-01-26 RO RO97-01580A patent/RO116898B1/ro unknown
- 1996-01-26 JP JP8525692A patent/JPH11501013A/ja not_active Abandoned
- 1996-01-26 RU RU97116154/04A patent/RU2164225C2/ru not_active IP Right Cessation
- 1996-01-26 CN CN96192042A patent/CN1071327C/zh not_active Expired - Fee Related
- 1996-01-26 DE DE69616515T patent/DE69616515T2/de not_active Expired - Fee Related
- 1996-01-26 EE EE9700147A patent/EE03564B1/xx not_active IP Right Cessation
- 1996-01-26 GE GEAP19963855A patent/GEP20001969B/en unknown
- 1996-01-26 KR KR1019970705755A patent/KR19980702358A/ko not_active Application Discontinuation
- 1996-01-26 EP EP96903708A patent/EP0811001B1/de not_active Expired - Lifetime
- 1996-01-26 SK SK1146-97A patent/SK284275B6/sk unknown
- 1996-01-26 CZ CZ19972607A patent/CZ294412B6/cs not_active IP Right Cessation
- 1996-01-26 UA UA97094674A patent/UA47424C2/uk unknown
- 1996-01-26 AU AU47703/96A patent/AU720036B2/en not_active Ceased
- 1996-01-26 PL PL96321866A patent/PL321866A1/xx unknown
- 1996-01-26 PT PT96903708T patent/PT811001E/pt unknown
- 1996-01-26 DK DK96903708T patent/DK0811001T3/da active
- 1996-02-20 ZA ZA961342A patent/ZA961342B/xx unknown
-
1997
- 1997-08-18 FI FI973380A patent/FI973380A/fi unknown
- 1997-08-20 NO NO973822A patent/NO308897B1/no not_active IP Right Cessation
- 1997-08-21 NZ NZ302116A patent/NZ302116A/en unknown
- 1997-09-01 BG BG101867A patent/BG62613B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69616515D1 (de) | Benzothiazindioxide als endothelinantagonisten | |
| ID26984A (id) | Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda | |
| BR0008688A (pt) | Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18 | |
| TR200100267T2 (tr) | İkameli anilid bileşimleri ve yöntemler. | |
| BG104899A (en) | Antipicornaviral compounds and compositions, their pharmaceutical use and materials for their synthesis | |
| FI973221A (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
| ATE195948T1 (de) | Endothelinantagonisten | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| NO20021503L (no) | Kinazolinoner | |
| MY116277A (en) | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation | |
| MX9304070A (es) | Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| NO20002408D0 (no) | 5-HT1F antagonister | |
| ID27656A (id) | Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
| ATE263139T1 (de) | 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |